Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Nicolaus F. Debatin"'
Autor:
Jan H. Müller, Henning Plage, Sefer Elezkurtaj, Tim Mandelkow, Zhihao Huang, Magalie C. J. Lurati, Jonas B. Raedler, Nicolaus F. Debatin, Eik Vettorazzi, Henrik Samtleben, Sebastian Hofbauer, Kira Furlano, Jörg Neymeyer, Irena Goranova, Bernhard Ralla, Sarah Weinberger, David Horst, Florian Roßner, Simon Schallenberg, Andreas H. Marx, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Maximilian Lennartz, Sarah Minner, Ronald Simon, Guido Sauter, Henrik Zecha, Thorsten Schlomm, Elena Bady
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
IntroductionTrophoblast cell surface antigen 2 (TROP2; EpCAM2) is a transmembrane glycoprotein which is closely related to EpCAM (EpCAM; EpCAM1). Both proteins share partial overlapping functions in epithelial development and EpCAM expression but hav
Externí odkaz:
https://doaj.org/article/e1665b34d1bc44738c48bdeeea0208d5
Autor:
Wenchao Li, Niclas C. Blessin, Ronald Simon, Martina Kluth, Kristine Fischer, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Björn Wellge, Tim Mandelkow, Nicolaus F. Debatin, Laura Pott, Doris Höflmayer, Maximilian Lennartz, Guido Sauter, Jakob R. Izbicki, Sarah Minner, Franziska Büscheck, Ria Uhlig, David Dum, Till Krech, Andreas M. Luebke, Corinna Wittmer, Frank Jacobsen, Eike Burandt, Stefan Steurer, Waldemar Wilczak, Andrea Hinsch
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Hodgkin’s lymphoma (HL) is characterized by a high background of inflammatory cells which play an important role for the pathogenesis of the disease. T cell immunoreceptor with Ig and ITIM domains (TIGIT) is an inhibitory immune checkpoint
Externí odkaz:
https://doaj.org/article/2b5a8c7c60d84f75a83d9a87293394bd
Autor:
Zhihao Huang, Nicolaus F. Debatin, Elena Bady, Jan H. Mueller, Tim Mandelkow, Magalie C. Lurati, Ronald Simon, David Dum, Guido Sauter, Franziska Büscheck, Doris Hoeflmayer, Sören Weidemann, Claudia Hube-Magg, Till Clauditz, Maximilian Lennartz, Eike Burandt, Niclas C. Blessin
Publikováno v:
Cancer Research. 83:6649-6649
Background: A combination of different immune-checkpoint-inhibitors (ICIs) have shown remarkable success in several tumor entities. However, the likelihood of positive response to ICIs is poor in most tumor entities and recent evidence suggests that
Autor:
Björn Wellge, Jakob R. Izbicki, Guido Sauter, David Dum, Ronald Simon, Sarah Minner, Stefan Steurer, Andreas M. Luebke, Tim Mandelkow, E Burandt, Frank Jacobsen, Till Krech, Georgia Makrypidi-Fraune, Corinna Wittmer, Wenchao Li, Martina Kluth, Claudia Hube-Magg, Kristine Fischer, Doris Höflmayer, Andrea Hinsch, Franziska Büscheck, Nicolaus F. Debatin, Ria Uhlig, Maximilian Lennartz, Waldemar Wilczak, Niclas C Blessin
Publikováno v:
Disease Markers, Vol 2019 (2019)
Disease Markers
Disease Markers
TIGIT is an inhibitory immune checkpoint receptor and a putative target for novel immune therapies. Here, we analysed two different types of tissue microarrays of healthy lymphatic and various inflamed tissues, colorectal and lung cancers, as well as
Autor:
Nicolaus F. Debatin, Elena Bady, Tim Mandelkow, Magalie C. Lurati, Ronald Simon, Claudia Hube-Magg, Maximilian Lennartz, Guido Sauter, Niclas C. Blessin
Publikováno v:
Cancer Research. 82:1935-1935
An increasing number of therapy regimens using a combination of different immune checkpoint inhibitors (ICIs) have shown remarkable results in several different tumor entities. However, the likelihood of a positive response rate to combined ICIs is p
Autor:
Ronald Simon, Maximilian Lennartz, Till Krech, Nicolaus F. Debatin, Wenchao Li, David Dum, Andrea Hinsch, Georgia Makrypidi-Fraune, Andreas M. Luebke, Doris Höflmayer, Stefan Steurer, Waldemar Wilczak, Jakob R. Izbicki, Frank Jacobsen, Claudia Hube-Magg, Niclas C Blessin, Sarah Minner, Eike Burandt, Björn Wellge, Tim Mandelkow, Corinna Wittmer, Franziska Büscheck, Martina Kluth, Guido Sauter, Ria Uhlig, Kristine Fischer
Publikováno v:
Oncology Letters
A characteristic feature of testicular seminoma is the abundance of immune cells in the tumor microenvironment, raising the possibility that immune checkpoint inhibitors may serve as a therapeutic option in these types of tumors. T cell immunorecepto
Autor:
Nicolaus F. Debatin, Tim Mandelkow, Wenchao Li, Ronald Simon, Franziska Büscheck, Corinna Wittmer, Björn Wellge, Niclas C Blessin, Eike Burandt, Andreas M. Luebke, Waldemar Wilczak, Laura Pott, Stefan Steurer, Eva Lueerss, Jakob R. Izbicki, Guido Sauter, Florian Lutz, Maria Christina Tsourlakis, Frank Jacobsen, Sarah Minner, Andrea Hinsch, Doris Höflmayer
Publikováno v:
Disease Markers, Vol 2019 (2019)
Disease Markers
Disease Markers
Small-cell cancer of the urinary bladder is a rare but highly aggressive disease. It is currently unclear whether immune checkpoint therapies that have been approved for urothelial carcinomas will also be efficient in small-cell carcinomas. In this s
Autor:
Sarah Minner, Ria Uhlig, Björn Wellge, Frank Jacobsen, David Dum, Wenchao Li, Claudia Hube-Magg, Tim Mandelkow, Andrea Hinsch, Maximilian Lennartz, Kristine Fischer, Franziska Büscheck, Jakob R. Izbicki, Stefan Steurer, Niclas C Blessin, Georgia Makrypidi-Fraune, Andreas M. Luebke, Corinna Wittmer, Nicolaus F. Debatin, Laura Pott, Waldemar Wilczak, Doris Höflmayer, Eike Burandt, Ronald Simon, Till Krech, Guido Sauter, Martina Kluth
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer
BMC Cancer
Hodgkin’s lymphoma (HL) is characterized by a high background of inflammatory cells which play an important role for the pathogenesis of the disease. T cell immunoreceptor with Ig and ITIM domains (TIGIT) is an inhibitory immune checkpoint receptor
Autor:
David Dum, Niclas C Blessin, Martina Kluth, Ria Uhlig, Franziska Büscheck, Waldemar Wilczak, Nicolaus F. Debatin, Frank Jacbosen, Claudia Hube-Magg, Wenchao Li, Maximillian Lennartz, Doris Höflmayer, Tim Mandelkow, Eike Burandt, Ronald Simon, Guido Sauter, Sarah Minner, Till Krech, Kristine Fischer, Andreas M. Luebke, Corinna Wittmer, Andrea Hinsch, Stefan Steurer, Jakob R. Izbicki
Publikováno v:
Cancer Research. 79:4104-4104
A characteristic feature of testicular seminoma is the abundance of immune cells in the tumor microenvironment, raising the possibility that immune checkpoint inhibitors could be a therapeutic option in these tumors. TIGIT (T cell immunoreceptor with
Autor:
Kristine Fischer, Claudia Hube-Magg, Andrea Hinsch, Georgia Makrypidi-Fraune, Björn Wellge, Waldemar Wilczak, Guido Sauter, Wenchao Li, Niclas C Blessin, Nicolaus F. Debatin, Martina Kluth, Tim Mandelkow, Ronald Simon
Publikováno v:
Cancer Research. 78:2142-2142
Hodgkin's lymphoma (HL) is characterized by a high background of inflammatory cells which play an important role for the pathogenesis of the disease. T cell immunoreceptor with Ig and ITIM domains (TIGIT) is an inhibitory immune checkpoint receptor a